Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
This analysis evaluates Biogen Inc.’s (NASDAQ: BIIB) recently announced definitive licensing agreement with TJ Biopharma for Greater China rights to experimental antibody felzartamab, a key late-stage asset in the firm’s immunology pipeline. The $850 million total potential deal unlocks full global
Biogen Inc. (BIIB) - Secures Exclusive Global Felzartamab Rights via Greater China Licensing Deal, Shares Rally - PEG Ratio
BIIB - Stock Analysis
3610 Comments
915 Likes
1
Pattricia
Registered User
2 hours ago
Real-time US stock gap analysis and overnight movement tracking to understand pre-market and after-hours trading activity for better opening positioning. We provide comprehensive extended-hours coverage that helps you anticipate opening price action and make informed pre-market decisions. Our platform offers gap analysis, overnight volume indicators, and extended hours charts for comprehensive coverage. Trade smarter with our comprehensive extended-hours analysis and tools designed for gap trading strategies.
👍 263
Reply
2
Zarek
Insight Reader
5 hours ago
This feels like something is about to break.
👍 281
Reply
3
Jamacia
Registered User
1 day ago
This made sense in a parallel universe.
👍 129
Reply
4
Jayce
Active Contributor
1 day ago
I’m convinced this is important, somehow.
👍 151
Reply
5
Lenoris
Consistent User
2 days ago
Great context provided for understanding market trends.
👍 255
Reply
© 2026 Market Analysis. All data is for informational purposes only.